We are live on
!
Find out more
GCM
Graham Capital Management Portfolio holdings
AUM
$4.14B
1-Year Est. Return
17.82%
This Fund
S&P 500
This Quarter
Est. Return
+8.47%
1 Year Est. Return
+17.82%
3 Year Est. Return
+41.13%
5 Year Est. Return
+43.39%
10 Year Est. Return
+274.46%
AUM
$6.62B
AUM Growth
+$902M
(+16%)
Cap. Flow
+$1.08B
Cap. Flow
% of AUM
16.3%
Top 10 Holdings %
Top 10 Hldgs %
50.26%
Holding
1,697
New
464
Increased
345
Reduced
451
Closed
433
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$19.3M |
| 2 |
Vanguard Morningstar Value ETF
VTV
|
+$18.6M |
| 3 |
Intercontinental Exchange
ICE
|
+$14.5M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$14.3M |
| 5 |
Monster Beverage
MNST
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$16.9M |
| 2 |
Johnson & Johnson
JNJ
|
+$16M |
| 3 |
Pacer Developed Markets International Cash Cows 100 ETF
ICOW
|
+$15.6M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$14.5M |
| 5 |
Vanguard Morningstar Growth ETF
VUG
|
+$10.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Financials | 5.16% |
| 3 | Industrials | 4.35% |
| 4 | Consumer Discretionary | 3.72% |
| 5 | Healthcare | 3.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Bioventus
BVS
$1.19B
| $119K | ﹤0.01% |
18,049
+3,464
| +24% | +$24.6K |
|
|
CRGX
1177
DELISTED
CARGO Therapeutics
CRGX
| $117K | ﹤0.01% |
+28,504
| New | +$122K |
|
1178
Sundial Growers
SNDL
$320M
| $117K | ﹤0.01% |
96,453
-82,061
| -46% | -$109K |
|
|
LAND
1179
Gladstone Land Corp
LAND
$360M
| $114K | ﹤0.01% |
+11,248
| New | +$110K |
|
|
TRTX
1180
TPG RE Finance Trust
TRTX
$618M
| $109K | ﹤0.01% |
14,130
-58,010
| -80% | -$442K |
|
|
WBTN
1181
WEBTOON Entertainment Inc
WBTN
$1.21B
| $100K | ﹤0.01% |
+11,038
| New | +$95.7K |
|
|
SVC
1182
Service Properties Trust
SVC
$1.07B
| $98.7K | ﹤0.01% |
+8,256
| New | +$89.2K |
|
|
ADAM
1183
Adamas Trust
ADAM
$883M
| $98.2K | ﹤0.01% |
14,650
-98,752
| -87% | -$626K |
|
1184
Fastly Inc
FSLY
$3.66B
| $97K | ﹤0.01% |
+13,742
| New | +$92.1K |
|
1185
Valens Semiconductor
VLN
$188M
| $96.6K | ﹤0.01% |
+36,725
| New | +$84.7K |
|
|
HPP
1186
Hudson Pacific Properties
HPP
$779M
| $96.4K | ﹤0.01% |
+5,025
| New | +$81.5K |
|
1187
Fate Therapeutics
FATE
$326M
| $95.9K | ﹤0.01% |
85,633
-54,431
| -39% | -$63.3K |
|
|
VTYX
1188
DELISTED
Ventyx Biosciences
VTYX
| $95K | ﹤0.01% |
44,372
-173,274
| -80% | -$280K |
|
1189
Crexendo
CXDO
$222M
| $94.6K | ﹤0.01% |
+15,583
| New | +$81.4K |
|
1190
Cognyte Software
CGNT
$680M
| $94K | ﹤0.01% |
10,168
-22,500
| -69% | -$221K |
|
1191
Arhaus
ARHS
$1.36B
| $93.9K | ﹤0.01% |
+10,833
| New | +$90.5K |
|
|
THRD
1192
DELISTED
Third Harmonic Bio
THRD
| $92.9K | ﹤0.01% |
+17,112
| New | +$85.3K |
|
1193
Treace Medical Concepts
TMCI
$309M
| $92.6K | ﹤0.01% |
+15,748
| New | +$103K |
|
1194
LSB Industries
LXU
$693M
| $92.2K | ﹤0.01% |
+11,817
| New | +$80.9K |
|
1195
AMC Global Media
AMCX
$489M
| $91.4K | ﹤0.01% |
14,583
-122,372
| -89% | -$773K |
|
|
BCYC
1196
Bicycle Therapeutics
BCYC
$292M
| $91.1K | ﹤0.01% |
+13,102
| New | +$104K |
|
1197
Editas Medicine
EDIT
$442M
| $89.4K | ﹤0.01% |
+40,633
| New | +$66.5K |
|
1198
Atea Pharmaceuticals
AVIR
$420M
| $89.4K | ﹤0.01% |
24,824
+8,122
| +49% | +$24.2K |
|
1199
Pulmonx
LUNG
$87.6M
| $88.7K | ﹤0.01% |
34,241
+17,618
| +106% | +$69.5K |
|
1200
Senseonics Holdings Inc
SENS
$366M
| $88.5K | ﹤0.01% |
+9,290
| New | +$108K |
|
Similar funds
SP
BOK
ZP
SHCM
AP
BHC
BG
MGP
Graham Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, Graham Capital Management held 1,697 positions worth $6.62B, up 16% from $5.72B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Graham Capital Management deployed $1.08B of net new capital in Q2 2025, opening 464 new positions and adding to 345 existing holdings. Its largest new stake was Vanguard Morningstar Value ETF: 110,000 shares worth $19.4M.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 5.5% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Citigroup, an estimated $16.9M trimmed.
- Graham Capital Management's largest Q2 2025 buy was Vanguard Morningstar Value ETF: 110,000 shares worth $19.4M.
- Graham Capital Management added most to iShares Bitcoin Trust in Q2 2025, an estimated $19.3M increase.
- Graham Capital Management's biggest Q2 2025 reduction was Citigroup, cutting an estimated $16.9M.
- Graham Capital Management fully exited Pacer Developed Markets International Cash Cows 100 ETF in Q2 2025, selling an estimated $15.6M.
- Graham Capital Management's ten largest holdings make up 50% of its $6.62B portfolio in Q2 2025.
- Graham Capital Management opened 464 new positions and closed 433 in Q2 2025.
- Graham Capital Management's portfolio value rose 16% quarter-over-quarter to $6.62B.
Based on Graham Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.